Pfizer Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 6,374.7 million compared to INR 6,362.6 million a year ago. Revenue was INR 6,617.1 million compared to INR 6,512.9 million a year ago. Net income was INR 3,110.7 million compared to INR 1,429.5 million a year ago. Basic earnings per share from continuing operations was INR 67.99 compared to INR 31.25 a year ago.
For the six months, sales was INR 12,303.7 million compared to INR 13,854.3 million a year ago. Revenue was INR 12,726.3 million compared to INR 14,127 million a year ago. Net income was INR 3,436.2 million compared to INR 3,428.6 million a year ago. Basic earnings per share from continuing operations was INR 75.11 compared to INR 74.94 a year ago.